Society for Translational Oncology

starstarstarstarstar

Highlights from STO's educational activities, including content associated with the Society and its journal The Oncologist.
www.sto-online.org TheOncologist.com

Podcasts.com RSS Feed URL

Society for Translational Oncology navigateright Episode

Clonal Hematopoiesis

Clonal hematopoiesis of indeterminate potential (CHIP) is a common, age-associated condition in individuals who do not have a hematologic malignancy or altered blood counts.  Consistent with the concept that CHIP is a pre-malignant state, CHIP is associated with a striking increased risk of hematologic malignancy.  In addition, individuals with CHIP have increased overall mortality and an increased risk of cardiovascular disease.

Benjamin Ebert, MD, PhD 

Dana-Farber Cancer Institute

STO gratefully acknowledges educational grants in partial support of this activity from:
Agios Pharmaceuticals
Amgen
Celgene Corporation
Novartis Pharmaceuticals Corp.
Pfizer Inc.